3 weeks ago all the media was discussing whether Australia could...

3 weeks ago all the media was discussing whether Australia could produce onshore mRNA vaccines due to licensing etc. Now licensing isn't an issue the biggest hurdle is out the way. IDT has all their ducks in a row, just a matter of time. Patience will be rewarded this financial year. The push on 14/4 and 22/4 IDT had was still on low volume. OBV remains high and barely any shares changing hands for the lower price action. Mostly occurring by those acquiring more from weak hands. This is poised ready for another run. Insiders have accumulated $4.3mil worth of shares over the past 3 months. CS still have about $400k worth that they've accumulated since March, and currently hold 4.9%. Only 23% of the market cap is in the general public's hands. 71% of CSL shares are in the general public's hands. IDT is tightly held so buying/accumulating will be difficult if those holding don't sell once the news is dropped. All good news for big % moves.